| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Mitchell Dean J is a Director at PRECIGEN, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $9.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | PGEN Precigen, Inc. | Director | Buy | 25,000 | $1.41 | $35,250.00 | +7.5% | -19.3% | -28.9% | |
| Mar 24, 2023 | PRAX Praxis Precision Medicines, Inc. | Director | Buy | 50,000 | $0.84 | $41,815.00 | +200.0% | +40.7% | +339.5% | |
| Jun 8, 2022 | PRAX Praxis Precision Medicines, Inc. | Director | Buy | 25,000 | $1.81 | $45,187.50 | New | +61.1% | -43.9% | |
| Aug 11, 2017 | PGEN Precigen, Inc. | Director | Buy | 5,000 | $18.33 | $91,639.50 | +38.2% | - | - |